Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

amprenavir

amprenavir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Agenerase CAPSULE, ORAL 50 mg, 150 mg      
Agenerase SOLUTION, ORAL 15 mg/mL      
Comments:

Fosamprenavir (Lexiva) is a pro-drug of amprenavir, with less GI adverse effects and a simpler dosing regimen than amprenavir.  Contact the physician for conversion from amprenavir to fosamprenavir.  700 mg fosamprenavir = 600 mg amprenavir

Reviewed:  February 28, 2006

Last updated: Feb. 16, 0002






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved